About

The Biomedical Science Discovery (BISDI) Program is a joint Abu Dhabi / Leuven initiative to champion biomedical research, nurture local talent and drive drug development innovation in Abu Dhabi by demystifying the function of mystery genes and target validation for diabetes and cancer immunotherapy.

icon about 1

Research for cures

Healthcare improvement is a strategic priority for the United Arab Emirates (UAE). By championing top research, the Biomedical Science Discovery (BISDI) Program, aspires to help create a world-class biomedical ecosystem in Abu Dhabi and Leuven to address these pressing goals to improve healthcare in the UAE and Belgium, even globally. 

icon strong ties

Strong ties

A collaborative relationship built on trust and friendship, supported by the governments and royals of UAE and Belgium.

icon innovation

Driving innovation

Innovative approaches that can be valorized.

icon excellence

Top research in twin labs

The BISDI program aspires to expand the pipeline of local talent to improve the healthcare in Abu Dhabi and beyond. BISDI’s vision is to transform lives via medical education and research, as a beacon for medical innovation in the UAE and beyond, to support regionally and globally relevant medical advancements.

"Through the collaboration between Khalifa University Center for Biotechnology and the University of Leuven-Flanders Institute, we hope to tackle challenges from different perspectives, thus enhancing our chances of success. We learn from each other and the people of both the UAE and Belgium will benefit from future discoveries."
Habiba Alsafar
Dr. Habiba Al Safar
Director, Khalifa University Center for Biotechnology, and Associate Professor of Genetics and Molecular Biology